Description: This article addresses the 2001 CSO Mortality Table and the implications for preneed insurance, for which the table has been deemed inadequate. The article explores interim measures such as additional reserves, treatment as substandard, and tax implications. There is also discussion of a model NAIC regulation which would mandate the use of 1980 CSO mortality for preneed as well as efforts to eventually establish a new preneed mortality table for valuation and nonforfeiture purposes.

Description: Discusses how the December 2017 US tax reform affects smaller insurance companies.

Description: Author highlights historical nonforfeiture and federal tax law changes, as they have impacted life product designs, in prognosticating about future product designs.

Description: Actuarial Guideline 38 has been one of the most discussed reserving changes in the past year. First proposed in late summer of 2004, several industry groups and LHATF have worked to reach consensus on this issue. The current draft is a compromise, sometimes referred to as the “CEO compromise” since the CEOs of several leading life insurers negotiated the language. From Small Talk Newsletter, November 2005, Issue No. 25.

Description: This article discusses the potential characteristics of health care reform and the associated impact on small insurance companies.

Description: Update on federal tax legislative and regulatory developments relevant to life insurers and their products.

Description: Recognizing the benefit for actuarial discussions about how COVID-19 will affect our work, the Smaller Insurance Company Section of the Society of Actuaries hosted “COVID-19: What a Smaller Insurance Company Actuary Needs to Know Virtual Town Hall” on April 17, 2020. The following delves into these presentations and discussions.

Description: Metadata for entire issue

Description: The SEC recently approved a financial disclosure rule mandating that a company must release material and market-moving information to all investors simultaneously. This article looks at the new rule designed to make financial disclosure fairer for all investors and how it may pose problems for larger insurers, while it may level the playing field for smaller insurers.

Description: This article discusses the new valuation concepts under Regulation XXX and the practical issues that need to be addressed by companies.